XTalks

JULY 19, 2024

Compounded GLP-1 medications, created by specialized pharmacies under a special US Food and Drug Administration (FDA) allowance due to ongoing shortage, have become increasingly popular for weight loss. The report also shows a rapid rise in compounding pharmacies.

Pharmacy 104

Pharmacy Drugs Production Sales 104

XTalks

SEPTEMBER 21, 2023

Among the companies Lilly has accused of selling non-US Food and Drug Administration (FDA) approved compounded products “fraudulently claiming to be Mounjaro” are medical spas, wellness centers and compounding pharmacies. Mounjaro, a dual GLP-1/GIP agonist was approved in May 2022 for type 2 diabetes.

Pharmacy 59

Pharmacy FDA Approval Drugs Containment 59

XTalks

JANUARY 29, 2025

In October 2024, the agency announced that the shortage of tirzepatide had been resolved with Zepbound and Mounjaro making it back on pharmacy shelves. Late last year, Zepbound brought in $1.26 billion in the third quarter and $1.9 billion in the fourth quarter, which were lower than both company and analyst expectations.

FDA Approval 71

FDA Approval Drugs Hormones Marketing 71

XTalks

JULY 10, 2023

With the remarkable success of its semaglutide products Wegovy and Ozempic for weight loss and type 2 diabetes, respectively (the latter also for weight loss through off-label prescribing), Novo Nordisk is cracking down on pharmacies making compounded versions of the glucagon-like peptide-1 (GLP-1) receptor agonist drugs.

Pharmacy 90

Pharmacy FDA Approval Licensing Licensing 90

XTalks

SEPTEMBER 19, 2023

The agency said if the companies fail to respond within the given time frame, it may pursue legal action, which could include seizing the products and/or a court order requiring the company to stop manufacturing or sale of the unapproved product. The FDA routinely looks out for illicit drugs on the market.

Production 105

Production Pharmacy Drugs Sales 105

pharmaphorum

FEBRUARY 25, 2022

The past two years have shone a spotlight on the UK life sciences industry. These efforts, as Nadhim Zahawi rightly said when he was Vaccines Minister, have led to the life sciences and pharma industry becoming a UK national treasure. An industry that will forever play a greater role in our everyday lives.

Life Science 98

Life Science Vaccination Vaccine Pharmacy 98

XTalks

FEBRUARY 8, 2024

Diabetes remains a critical global challenge, affecting millions of lives and commanding significant attention from the medical, life sciences and pharmaceutical sectors. Read on to learn more about the top 15 diabetes drugs in 2023, based on 2022 sales statistics. mL subcutaneous solution (2 mg/1.5 billion in Q4 2022.

Sales 52

Sales Insulin FDA Approval Drugs 52

pharmaphorum

JANUARY 5, 2023

Dwindling college pipeline: The already short supply of pharmacists and pharm techs is further strained by the decreasing number of pharmacy grads entering the industry. A top 10 pharmacy school doesn’t always breed the best candidates, nor does having experience working at a “top-tier” company. Recruiting.

Life Science 90

Life Science Pharmacy Marketing Sales 90

pharmaphorum

JANUARY 26, 2021

Life sciences companies need to rethink their customer engagement paradigms in light of changing customer preferences. Amazon is making a serious global move into healthcare delivery with the acquisition of PillPack, and its recent launch of Amazon Pharmacy. No more ‘business as usual’ for pharma’s customer engagement.

Clinical Trials 141

Clinical Trials Clinical Trials Sales Life Science 141

XTalks

MAY 17, 2024

Related: Compounded Versions of Mounjaro Being Sold at Pharmacies and Spas Prompt Lawsuits “Patient safety is Lilly’s highest priority. It implored state and federal regulators to take action and “punish compounding pharmacies, counterfeiters and others who put patients at risk by selling unsafe products claiming to be tirzepatide.”

Sales 52

Sales FDA Approval Pharmacy Production 52

XTalks

JUNE 3, 2024

As interchangeable biosimilars, the intravitreally (in the eye) administered solutions can be subbed for the reference product Eylea at a pharmacy counter without needing a prescription. As one of Regeneron’s best-selling drugs, US sales of Eylea were approximately $5.89 In 2022, global Eylea sales hit $9.6 billion in 2023.

FDA Approval 98

FDA Approval Sales Clinical Trials Clinical Trials 98

XTalks

MARCH 22, 2023

In October 2022, Xtalks celebrated two decades of bringing diverse stakeholders in the life science industry together through first holding physical events, then soon after, hosting exclusively online events. More potential patients equal more prescriptions which equals higher sales and bigger profits.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

XTalks

OCTOBER 11, 2024

In 2023, Arexvy captured two-thirds of US RSV vaccine sales, largely through contracts with major pharmacies. While sales have dipped this year, GSK remains the dominant player, supported by Phase III data and continuing global expansion efforts. This has reportedly led to a two-thirds drop in vaccine demand this season.

Vaccination 103

Vaccination Vaccine Immune Response Trials 103

XTalks

JANUARY 24, 2022

Gilead Sciences has been seizing counterfeit versions of its HIV drugs Biktarvy and Descovy since last year and is now suing distributors who have been behind selling the illicit medications. The drugs were sold to US pharmacies by an unauthorized web of distributors who faked bottle labels and documentation, threatening patient safety.

Drugs 98

Drugs Pharmacy Production Containment 98

XTalks

NOVEMBER 1, 2024

In this blog, we highlight the top 20 best-selling neurology drugs to watch in 2024, based on 2023 sales statistics. We discuss each drug’s approved uses, sales performance and why they’ve become essential in the neurology space. Related: Top 30 Drugs to Watch in 2024: Insights from 2023 Sales Data 1. billion in the US and $4.1

FDA Approval 85

FDA Approval Drugs Botox Sales 85

XTalks

AUGUST 22, 2024

While Mounjaro and Zepbound are back in stock, they’re still listed as unavailable on Lilly’s third-party provider Amazon Pharmacy. Novo also reported an increase of 25 percent in sales in the first half of 2024, totaling 133.4 billion Danish kroner ($27.07

Drugs 111

Drugs Manufacturing Production Pharmacy 111

Pharma in Brief

OCTOBER 29, 2020

This supporting documentation is no longer required if: the drug has been previously authorized by the SAP for the same medical emergency; the drug is authorized for sale without terms and conditions ( e. any drug identification number or natural product number previously issued for the drug has not been cancelled for safety reasons.

Regulation 40

Regulation Sales Drugs Manufacturing 40

XTalks

AUGUST 3, 2023

While most post-marketing activities are typically oriented towards marketing, sales, and commercialization of the drug, pharmacovigilance is fundamentally patient-centric, focusing on the safety and efficacy of pharmaceutical products once they reach the market.

Regulation 97

Regulation Marketing Life Science Drugs 97

XTalks

OCTOBER 10, 2024

While good news for users, the FDA decision sparked a heated response from the compounding pharmacy sector, which has filed a lawsuit against the agency claiming its actions were arbitrary and unlawful. During this time, compounding pharmacies were permitted to produce lower-cost versions of the injectable medications. “The

Pharmacy 52

Pharmacy Drugs Production Branding 52

XTalks

JULY 3, 2024

Related: Senator Maggie Hassan Blasts GSK for Discontinuing Common Children’s Asthma Inhaler to Dodge Price Cap Verona said it is “fully staffed to launch” and expects Ohtuvayre to be available in the third quarter of 2024 “through an exclusive network of accredited specialty pharmacies.” billion by 2029.

Drugs 105

Drugs Clinical Trials Clinical Trials FDA Approval 105

XTalks

NOVEMBER 15, 2024

More than 60 percent of participants encountered delays or issues when refilling their GLP-1 prescription, often resulting in switching pharmacies, skipping or reducing doses or changing brands. By 2029, the drugs are expected to dominate the market, capturing 83 percent of sales, with Eli Lilly’s Mounjaro predicted to lead.

Drugs 105

Drugs Nurses Pharmacy Branding 105

Pharma in Brief

NOVEMBER 29, 2020

The other interim orders include: Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19 (signed March 18, 2020). Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19 (signed September 16, 2020). Interim Order Context.

Drugs 52

Drugs Sales FDA Approval Compliance 52

XTalks

NOVEMBER 27, 2024

percent of US sales revenue from Niktimvo. Syndax said it anticipates that the 110 mg and 160 mg tablets of Revuforj will be available for purchase in the US through a network of specialty distributors and pharmacies starting in November. The agreement will conclude once Royalty Pharma achieves 2.35 times its initial investment.

FDA Approval 99

FDA Approval Drugs Gene Trials 99

XTalks

MARCH 7, 2023

In a company presentation, Apellis revealed the list price of Syfovre to be $2,190 per vial before discounts and said it would be made available through specialty distributors and pharmacies across the US. The drug generated an estimated $65 million in net sales in 2022. The company expects to launch the drug this month.

FDA Approval 98

FDA Approval Drugs Sales Trials 98

XTalks

OCTOBER 25, 2023

Ashish Jha, dean of the Brown School of Public Health and the former White House COVID-19 response coordinator, told CNN that a self-administered flu vaccine option could be even more accessible if it were available to buy on pharmacy shelves, rather than through a gatekeeper.

Vaccination 59

Vaccination Vaccine Sales Pharmacy 59

pharmaphorum

AUGUST 5, 2022

Such inorganic growth is no longer viable, argues Pervaise Khan, Accenture’s UK Life Sciences Lead. This team will need to be equipped to develop novel science and technologies, while also evaluating and managing collaborations that provide access to these assets. About the Author. References. [1] March 2022. [2]

Life Science 52

Life Science Marketing Vaccination Vaccine 52

pharmaphorum

OCTOBER 3, 2022

Over the last 20 years, Kapoor has led Indegene’s sales and business development efforts in the APAC region, including China and the European and North American regions. He holds a bachelor’s degree in Pharmacy from St. Prior to joining Indegene, Kapoor held various marketing positions in the Indian pharma industry. About the author.

Branding 116

Branding Doctors Doctor Compliance 116

XTalks

MARCH 28, 2024

Related: Top 15 Cardiovascular Disease Drugs in 2023 by 2022 Sales Data Merck said Winrevair will likely be available by the end of April through select specialty pharmacies in the US. In 2023, sales of Uptravi hit $1.6 Merck has set the list price of Winrevair at $14,000 per vial. The PAH market was valued at $7.3

FDA Approval 81

FDA Approval Clinical Trials Clinical Trials Trials 81

pharmaphorum

JUNE 15, 2021

Not surprisingly then, payers feel the pain: increased focus on financial consideration causes friction between pharmacy benefit managers, payers, HCPs and patients. Even with New Science’s more effective, personalised treatments, there isn’t enough money in the system to pay for them”. About the author.

Clinical Trials 90

Clinical Trials Clinical Trials Development Marketing 90

XTalks

NOVEMBER 7, 2023

Educational Requirements and Recommendations Typically, individuals in these roles are either medical doctors (MDs), pharmacists with a doctor of pharmacy degree (PharmD) or hold doctorates of philosophy (PhDs). Medical science liaisons are in great demand due to their critical function within life science organizations.

Doctors 59

Doctors Doctor Life Science Production 59

XTalks

NOVEMBER 2, 2023

It is specifically approved as an interchangeable biosimilar, which means it may be substituted for the original product at the pharmacy level by a pharmacist without the need for a healthcare professional to prescribe the change. billion in sales, accounting for ten percent of Johnson & Johnson’s revenue.

FDA Approval 59

FDA Approval Production Dermatology Sales 59

XTalks

NOVEMBER 28, 2023

Since it is now designated by the FDA as an “interchangeable” product, Byooviz may be substituted at the pharmacy for the reference product without the intervention of the prescribing healthcare provider, according to state law.

Production 98

Production Marketing Development Pharmacy 98

XTalks

NOVEMBER 9, 2023

Since its approval in May 2022, Mounjaro sales have hit $1.4 In the first half of 2023, sales of Ozempic and Wegovy rose by 58 percent and 363 percent, respectively. Related: Compounded Versions of Mounjaro Being Sold at Pharmacies and Spas Prompt Lawsuits Zepbound will be available at a list price of $1,059.87

FDA Approval 59

FDA Approval Manufacturing Drugs Pharmacy 59

pharmaphorum

JANUARY 27, 2021

Its sale was never approved in the US because the FDA did not think sufficient testing had taken place. The healthcare and life science sectors have the opportunity to promote and publicize such initiatives widely, so everyone can understand how researchers are being guided in their work and how trials are conducted.

Research 52

Research Clinical Trials Clinical Trials Vaccination 52

XTalks

JUNE 12, 2023

Abbott Laboratories reported that the sales from its Diagnostics and Medical Device divisions in 2022 surpassed the company’s initial forecast. The remarkable performance in 2022 was driven largely by the sales of COVID-19 testing kits, including the BinaxNOW COVID-19 Ag test and its at-home self-test version. percent from $27.06

FDA Approval 98

FDA Approval Production Sales In-Vitro 98

XTalks

FEBRUARY 8, 2021

As a subset of biosimilars, interchangeable biological products can be substituted for the reference product at the pharmacy level, without the input of the prescribing physician. What is an Interchangeable Biological Product?

Production 78

Production Insulin Branding Generic Drugs 78

XTalks

MARCH 8, 2024

This means they can be substituted for the reference product at a pharmacy without the need for instruction from a prescriber. According to Amgen’s last earnings report , Prolia sales increased 12 percent last year to more than $4 billion, and Xgeva’s jumped five percent from last year to $2.1

Drugs 59

Drugs FDA Approval Production Immune Response 59